- US12441796utility2025Antibody Constructs for CDH19 and CD30 cites
- US12435139utility2025Antibody Constructs for DLL3 and CD30 cites
- US12428491utility2025PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs0 cites
- US12304952utility2025Antibody Constructs for DLL3 and CD30 cites
- US12297292utility2025Antibody Constructs for CDH19 and CD30 cites
- US12281172utility2025Cross-species-specific Psmaxcd3 Bispecific Single Chain Antibody0 cites
- US12281175utility2025Binding Molecules for BCMA and CD30 cites
- US12281176utility2025Binding Molecules for BCMA and CD30 cites
- US12258404utility2025Bispecific Antibody Construct Directed to MUC17 and CD30 cites
- US12258411utility2025Anti-ccr8 Antibodies and Uses Thereof0 cites
- US12152078utility2024Nucleic Acids Encoding Anitbody Constructs Binding EGFR VIII and CD30 cites
- US11987633utility2024Cross-species-specific Single Domain Bispecific Single Chain Antibody0 cites
- US11925684utility2024Compositions Comprising Cross-species-specific Antibodies and Uses Thereof0 cites
- US11926666utility2024Bispecific Antibody Constructs for CDH3 and CD30 cites
- US11661462utility2023Optimized Cross-species Specific Bispecific Single Chain Antibody Contructs0 cites
- US11633408utility2023Prevention of Adverse Effects Caused by CD3 Specific Binding Domains0 cites
- US11597766utility2023Treatment of Acute Lymphoblastic Leukemia0 cites
- US11591396utility2023Antibody Constructs for DLL3 and CD30 cites